Aim Bulletin
Poolbeg Pharma says Gilead in favour of its combination with Hookipa
Poolbeg Pharma updated the market on its potential combination with Hookipa Pharma on Friday, clarifying Gilead Sciences’ role in the proposed concurrent fundraise.
Tower Resources executes two big farm-out deals
Tower Resources announced on Friday that it has executed two significant farm-out agreements with Prime Global Energies, covering its Thali licence offshore Cameroon and PEL96 offshore Namibia.
Anpario flags stronger-than-expected full-year results
Animal feed additive manufacturer Anpario flagged a stronger-than-expected operating performance for the year ended 31 December on Friday.
Enteq reports product development progress, warns of shorter cash runway
Enteq Technologies updated the market on the development and commercialisation of its ‘Steer-At-Bit Enteq Rotary’, or ‘SABER Tool’ technology on Friday, following recent testing and customer engagement, although its shares were plunging as it also warned of a shorter cash runway than previously expected.
Panthera subsidiary progresses arbitration proceedings against India
Panthera Resources updated the market on arbitration proceedings against the Republic of India on Friday, initiated by its Australian subsidiary Indo Gold (IGPL).
Thor announces positive drilling results from Segilola Gold Mine
Thor Explorations announced positive results from its ongoing diamond drilling programme at the Segilola Gold Mine in Nigeria on Friday, which targeted the down-plunge extensions beneath the current open-pit limits.
Woodbois shares slide as bank calls in loans
Woodbois announced on Friday that Nykredit Bank has terminated loan facilities provided to the company’s subsidiary, Woodbois International, demanding repayment in full by 17 January.
Arecor to wind up operations at Tetris Pharma subsidiary
Arecor Therapeutics announced plans to cease operations within its subsidiary Tetris Pharma during 2025 on Friday, adding that it had mutually agreed with Xeris BioPharma to return the rights to Ogluo - a ready-to-use glucagon auto-injector for severe hypoglycemia.
One Media iP reports stable revenue as it focuses on core business
One Media IP reported stable full-year revenue in a trading update on Friday, following a strategic divestment to sharpen its focus on core operations.
DBAY Advisors to buy Alliance Pharma in £349.7m deal
AIM-listed Alliance Pharma said on Friday that it has agreed to be bought by asset management firm DBAY Advisors in a £349. 7m deal.
Kingswood appoints interim CEO as permanent boss
AIM-listed wealth and investment management group Kingswood has announced that it will be making Peter Coleman its permanent boss after six months serving in an interim capacity.
H&T Group reports robust fourth-quarter trading
Pawnbroker and jewellery retailer H&T Group reported a robust performance in its critical fourth quarter on Thursday, in line with management expectations.
PetroTal reports improved fourth quarter production
Oil producer PetroTal said in an update on Thursday that its corporate production in the fourth quarter averaged about 19,150 barrels of oil per day, bolstered by volumes from its newly-acquired Block 131.
Cohort subsidiary secures Italian submarine contract extension
Technology company Cohort announced on Thursday that its German subsidiary ELAC Sonar has been awarded a €16. 4m contract amendment.
Central Asia Metals confident after year of mixed production results
Central Asia Metals, the operator of the Kounrad copper recovery plant in Kazakhstan and the Sasa zinc-lead mine in North Macedonia, said in an update on Thursday that it achieved full-year copper production of 13,439 tonnes at Kounrad, within its guidance range, despite a slight decline from 2023’s output of 13,816 tonnes.
Boohoo reiterates backing of co-founder as boardroom battle heats up
Boohoo Group has reiterated its call to shareholders to vote against moves by Mike Ashley’s Frasers Group to overhaul the board, including ousting co-founder Mahmud Kamani.
Physiomics project gets regulatory and ethical approval
Mathematical modelling, data science and biostatistics specialist Physiomics announced on Wednesday that its Innovate UK-funded ‘PREDICT-ONC’ project had received both regulatory and ethical approval.
Cambridge Cognition product used in schizophrenia treatment trial
Cambridge Cognition announced the use of its ‘CANTAB’ cognitive assessment product in two phase three clinical trials conducted by Bristol Myers Squibb for ‘Cobenfy’, a newly FDA-approved treatment for schizophrenia.
Aquis Exchange not proceeding with Cboe EU tape JV
Aquis Exchange announced on Wednesday that the joint venture behind SimpliCT, its partnership with Cboe Europe, would not proceed with a bid to provide the European equities consolidated tape.
Global Petroleum completes final LiDAR data from Juno
Global Petroleum announced the completion and delivery of final data from airborne LiDAR surveys for the Juno project in Western Australia on Wednesday, including high-resolution digital terrain model (DTM) mosaics at 0. 5 and one metre resolutions, along with detailed digital imagery of the ground surface.